Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA sequencing of BM-derived senescent MDSCs treated or not with Romidepsin

ABSTRACT: RNA sequencing of BM-derived senescent MDSCs treated or not with Romidepsin

PROVIDER: PRJNA822086 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18579249.fastq.gz	Fastqsanger.gz
	SRR18579250.fastq.gz	Fastqsanger.gz
	SRR18579251.fastq.gz	Fastqsanger.gz
	SRR18579252.fastq.gz	Fastqsanger.gz
	SRR18579253.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

RNA sequencing of BM-derived senescent MDSCs treated or not with Romidepsin

Project description:RNA sequencing of BM-derived senescent MDSCs treated or not with Romidepsin

2023-03-02 | GSE199921 | GEO

RNA sequencing of BM-MDSCs exposed to high potassium

Project description:RNA sequencing of BM-MDSCs exposed to high potassium

| PRJNA1251987 | ENA

RNA sequencing of myelod derived suppressor cells (MDSCs) and Bone marrow (BM)

Project description:RNA sequencing of myelod derived suppressor cells (MDSCs) and Bone marrow (BM)

| PRJNA837621 | ENA

Chip seq of in vitro induced senescent myeloid cells treated with HDAC inhibitor

Project description:To understand the epigenetic regulations in in vitro induced senescent myeloid cells, we used Romidepsin (regulator of hyston H3) and we analysed how the genes get regulated.

2023-03-02 | GSE223014 | GEO

RNA sequencing of BM-MDSCs exposed to high potassium

Project description:Total RNA was extracted from BM-MDSCs treated with or without additional 34.7 mM KCl. Libraries were prepared according to standard Illumina protocols. RNA sequencing was performed by Shanghai Biotechnology Corporation (Shanghai, China). The raw reads were filtered by Seqtk before mapping to genome using Hisat2 (version:2.0.4). The fragments of genes were counted using stringtie (v1.3.3b) followed by TMM (trimmed mean of M values) normalization. Differential gene expression analysis was conducted using DESeq2 (version 1.20.0), with a significance threshold of a corrected p-value < 0.05 and an absolute fold change ≥ 2. The distribution of differentially expressed genes in KEGG pathways was analyzed using the clusterProfiler R package (version 3.8.1) to identify key biological mechanisms.

2025-05-28 | GSE294895 | GEO

Expression data of Panc1 cells treated with romidepsin and tamoxifen

Project description:Tamoxifen enhances romidepsin-induced senescence in pancreatic cancer cells. We compared gene-expression profile among untreated control, romidepsin-treated, tamoxifen-treated, and romidepsin plus tamoxifen-treated Panc1 cells.

2021-08-21 | GSE182526 | GEO

miRNA expression in myeloid-derived suppressor cells (MDSCs) treated with or without whole ?-glucan particles (WGP)

Project description:Murine MDSCs isolated from the spleens of Lewis lung carcinoma mice were treated with or without WGP, and then miRNA array was used to analyze the differentailly expressed miRNAs. Murine MDSCs were isolated from the spleens of Lewis lung carcinoma tumor-bearing mice, and the sorted MDSCs were stimulated with or without 100 µg/ml WGP for 24 h. Then, the total RNA was extracted to perform miRNA array to analyze the differentially expressed miRNAs in MDSCs treated with or without WGP

2015-06-26 | E-GEOD-67578 | biostudies-arrayexpress

Expression data of MOLT-4 cells treated with romidepsin and tamoxifen

Project description:Tamoxifen enhaces romidepsin-induced apoptosis in T-cell malignant cells. We compared gene-expression profile among untreated control, romidepsin-treted,

2020-02-21 | GSE145606 | GEO

Effect of Romidepsin treatment on patient-derived liver cancer cells

Project description:Romidepsin displayed potent antitumor activity in our lenvatinib-resistant PDCs, we wanted to investigate the underlying mechanism of how romidepsin initiated susceptibility to conquer lenvatinib resistance in liver cancer.

2024-03-17 | GSE227751 | GEO

Effect of mtDNA on MDSCs

Project description:Mitochondrial dysfunction is a hallmark of cellular senescence. Mitochondrial DNA (mtDNA) functions as a damage-associated molecular pattern that activates the innate immune system when released extracellularly. We examined whether senescent cells release mtDNA into the extracellular space and the consequences of this exogenous mtDNA in innate immunity. Both primary senescent cells and tumor cells undergoing therapy-induced senescence release mtDNA into the extracellular space. In vivo cross-species xenograft models using human prostate cancer cells in immunocompromised mice demonstrated the selective uptake of human mtDNA by mouse polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) within the tumor microenvironment (TME). In vitro trans-well experiments confirmed the uptake of mtDNA by mouse PMN-MDSCs through extracellular vesicles (EVs). Internalized mtDNA enhanced the immunosuppressive activity of PMN-MDSCs via cGAS-STING-NF-_B activation, promoting tumor progression. Mechanistically, mtDNA released from senescent cells was mediated by voltage-dependent anion channels (VDAC), and pharmacological inhibition of VDAC reduced extracellular mtDNA levels, reversing PMN-MDSC-driven immunosuppression and improving the efficacy of chemotherapy in prostate cancer models. Thus, inhibiting mtDNA release may enable reprogramming of the immune suppressive microenvironment in patients treated with chemotherapy.

2025-03-24 | GSE290948 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data